LONDON, Nov. 24, 2016 /PRNewswire/ -- The global adhesion barriers market is expected to grow at a CAGR of 8.4% during the forecast period of 2016 to 2021. This market is projected to reach USD 1,216.8 million by 2021 from USD 812.5 million in 2016. Rising geriatric population, increasing number of surgeries, and growth in the number of sports-related and hand & wrist injuries are the major factors driving the adhesion barriers market. In this report, the adhesion barriers market is segmented on the basis of product type, product form, application, and geography. On the basis of product type, the market is segmented into natural adhesion barriers and synthetic adhesion barriers. Synthetic adhesion barriers include hyaluronic acid, regenerated cellulose, polyethylene glycol (PEG), and other synthetic adhesion barriers; whereas, natural adhesion barriers include collagen & proteins and fibrin-based products. On the basis of product form, the market is segmented into film formulations, gel formulations, and liquid formulations. Based on applications, the market is segmented into neurological surgeries, cardiovascular surgeries, general surgeries, orthopedic surgeries, thoracic surgeries, gynecological surgeries, urological surgeries, reconstructive surgeries, and other surgeries. In 2015, the synthetic adhesion barriers market accounted for the largest share of the adhesion barriers market. The large share of this segment is majorly attributed to widespread use of products such as hyaluronic acid and regenerated cellulose in surgeries. The other synthetic adhesion barriers segment is expected to grow at the highest CAGR during the forecast period due to increasing efforts by companies in introducing combinations of synthetic adhesion barriers. In 2015, North America accounted for the largest share of the global adhesion barriers market, followed by Europe, Asia-Pacific, Latin America, and Middle East and Africa. Asia-Pacific is expected to be the fastest-growing regional segment during the forecast period, primarily due to improvements in the region's healthcare infrastructure, increasing awareness about adhesion barriers, and rising disposable incomes. Some key players in this market include Johnson & Johnson (U.S.), Sanofi Group ( France), Atrium Medical Corporation (U.S.), Baxter International Inc. (U.S.), Medtronic Plc. (U.S.), C. R. Bard, Inc. (U.S.), Integra Lifesciences Corporation (U.S.), Anika Therapeutics Inc. (U.S.), FzioMed, Inc. (U.S.), and MAST Biosurgery AG ( Switzerland). Reasons to Buy the Report: The report will enrich both established firms as well as new entrants/smaller firms, and allow them to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report could use one or a combination of the below-mentioned strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for increasing their market shares.